Recommend Natco Pharma, Glenmark and Ashok Leyland among midcap stocks: Tirthankar Patnaik

In a chat with ET Now, Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets, shares his views on midcap stocks.

ET Now: Give us your high conviction midcap buy idea.

Tirthankar Patnaik: There are a number of midcap plays that we have been pushing. Without going into specifics of stocks, in the pharma space, we like Natco Pharma. Glenmark is another stock that we like.

In the auto space, Ashok Leyland is a stock that we like and in the finance space, we have liked Repco. So there are various midcap stocks that we believe could be fairly okay. In the private bank space, Yes and IndusInd are two banks we have been pushing aggressively.

ET Now: What is that you like Natco? Are you confident that they will go ahead with the drug launch of Copaxone?

Tirthankar Patnaik: The earnings CAGR for the stock would be around odd 20% for the next two to three years and from the midcap space, even in terms of valuations, numbers are fairly okay and that is one reason why we like the stock.